𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Liver regeneration in normal and alloxan-induced diabetic rats

✍ Scribed by Barra, Rosemary ;Hall, James C.


Publisher
John Wiley and Sons
Year
1977
Tongue
English
Weight
717 KB
Volume
201
Category
Article
ISSN
0022-104X

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The effects of alloxan‐induced diabetes on liver regeneration were investigated. Normal and diabetic rats were sacrificed at eight time periods between 16 hours and 4 weeks following two‐thirds partial hepatectomy or sham operation. The results indicate that alloxan‐induced diabetes delays but does not prevent liver regeneration following partial hepatectomy. This delay is indicated by a depressed synthesis of RNA, DNA and protein during the first post‐operative day and a lack of mitotic figures in the 24‐hour sample. In addition, the synthesis of these three cellular constituents did not return to control levels as rapidly in the diabetics. Compared with the sham operated animals, the concentrations of total serum protein remained depressed longer in the diabetic hepatectomized animals. The data indicate that the metabolic alterations associated with alloxan diabetes delay the onset of the regenerative process and prolong the recovery period.


πŸ“œ SIMILAR VOLUMES


Nerve regeneration in diabetic rats
✍ Srdan Babovic; Andrew M. Ress; A. Lee Dellon; Michael F. Angel; Michael J. Im; P πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 34 KB

This study evaluated the capacity of diabetic rats to recover the ability to walk after nerve repair or nerve graft of the posterior tibial nerve at thigh level. Functional recovery of the posterior tibial nerve was evaluated by walking track analysis during regeneration in streptozotocin-induced di

Pharmacokinetics and pharmacodynamics of
✍ Yu C. Kim; Eun Y. Oh; So H. Kim; Myung G. Lee πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 107 KB πŸ‘ 2 views

The pharmacokinetic and pharmacodynamic parameters of torasemide were compared after intravenous administration at a dose of 2 mg/kg to diabetic rats induced by alloxan (DMIA) or streptozotocin (DMIS), and their respective control rats. It was reported that torasemide was mainly metabolized via CYP2